Patents by Inventor Ralf Jager

Ralf Jager has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220305020
    Abstract: Disclosed herein are compositions and methods for attenuating stress-induced mental fatigue in subject in need thereof by administering to the subject a composition comprising from about 2 mg to about 800 mg of paraxanthine. In certain embodiments, paraxanthine is present in the composition in amount from about 20 mg to about 600 mg. In further embodiments, paraxanthine is present in the composition in amount from about 50 mg to about 400 mg. According to certain embodiments, fatigue attenuated by the instantly disclosed method is a result of physical stress on the subject. Physical stresses that may result in mental fatigue include, but are not limited to, periods of intense exercise.
    Type: Application
    Filed: March 28, 2022
    Publication date: September 29, 2022
    Inventors: Ralf Jäger, Martin Purpura, Shawn Wells, Kylin Liao
  • Publication number: 20220110903
    Abstract: Compositions and methods of treatment and prevention for trauma-related brain injury are disclosed herein. In certain aspects, disclosed is a method for preventing, alleviating or treating trauma-related brain injury in a subject in need thereof comprising administering to the subject a composition comprising docosahexaenoic acid and eicosapentaenoic acid.
    Type: Application
    Filed: September 20, 2021
    Publication date: April 14, 2022
    Inventors: Martin Purpura, Ralf Jäger, Mark Olson
  • Publication number: 20210212953
    Abstract: The disclosed are shelf-stable beta-hydroxyisovaleric acid containing soft gel compositions and methods for making such compositions. In certain aspects, disclosed compositions comprise a plant-based capsule shell and a liquid formulation comprising beta-hydroxyisovaleric acid and at least one excipient, wherein the soft gel capsule is shelf-stable. In certain aspects, the excipient is selected from selected from choline salt, betaine, phosphatidylcholine, alpha-glycerophosphocholine, carnitine, adenosine 5?-triphosphate, or a combination thereof.
    Type: Application
    Filed: March 30, 2021
    Publication date: July 15, 2021
    Inventors: Martin Purpura, Ralf Jäger, Jie Gu, Xiong Zheng, lingwei dai, Yaohua Zhang
  • Publication number: 20210186077
    Abstract: Some embodiments relate to nutritional supplements comprising rice protein isolate. Some embodiments of the nutritional supplement comprise less than about 90 mg of leucine per gram of rice protein isolate and less than about 50 mg of lysine per gram of rice protein isolate. Some embodiments pertain to methods of using the nutritional supplements described herein to achieve one or more of weight gain, weight maintenance, growth, muscle growth, muscle maintenance, decreased muscle loss, or improved exercise training results.
    Type: Application
    Filed: March 5, 2021
    Publication date: June 24, 2021
    Inventors: David Janow, Ralf Jäger
  • Patent number: 10959957
    Abstract: The disclosed are shelf-stable beta-hydroxyisovaleric acid containing soft gel compositions and methods for making such compositions. In certain aspects, disclosed compositions comprise a plant-based capsule shell and a liquid formulation comprising beta-hydroxyisovaleric acid and at least one excipient, wherein the soft gel capsule is shelf-stable. In certain aspects, the excipient is selected from selected from choline salt, betaine, phosphatidylcholine, alpha-glycerophosphocholine, carnitine, adenosine 5?-triphosphate, or a combination thereof.
    Type: Grant
    Filed: May 25, 2017
    Date of Patent: March 30, 2021
    Assignee: TSI Group Ltd.
    Inventors: Martin Purpura, Ralf Jager, Jie Gu, Xiong Zheng, Iingwei Dai, Yaohua Zhang
  • Patent number: 10869843
    Abstract: Phosphatidic acid is administered orally to increase muscle mass and strength in exercising mammals. Phosphatidic acid is administered orally to aging, bedridden or cachectic patients to improve nitrogen balance. The preferred form of phosphatidic acid for administration is phosphatidic acid-enriched lecithin. Creatine is co-administered orally to increase the muscle-building and strength effect. Other suggested additives include nutritional and herbal supplements, micronutrients and hormones.
    Type: Grant
    Filed: November 23, 2011
    Date of Patent: December 22, 2020
    Assignee: CHEMI NUTRA
    Inventors: Lorenzo De Ferra, Marvin Heuer, Scott Hagerman, Martin Purpura, Ralf Jager
  • Publication number: 20200315234
    Abstract: Some embodiments relate to nutritional supplements comprising rice protein isolate. Some embodiments of the nutritional supplement comprise less than about 90 mg of leucine per gram of rice protein isolate and less than about 50 mg of lysine per gram of rice protein isolate. Some embodiments pertain to methods of using the nutritional supplements described herein to achieve one or more of weight gain, weight maintenance, growth, muscle growth, muscle maintenance, decreased muscle loss, or improved exercise training results.
    Type: Application
    Filed: November 22, 2019
    Publication date: October 8, 2020
    Inventors: David Janow, Ralf Jäger
  • Publication number: 20190239548
    Abstract: Some embodiments relate to nutritional supplements comprising rice protein isolate. Some embodiments of the nutritional supplement comprise less than about 90 mg of leucine per gram of rice protein isolate and less than about 50 mg of lysine per gram of rice protein isolate. Some embodiments pertain to methods of using the nutritional supplements described herein to achieve one or more of weight gain, weight maintenance, growth, muscle growth, muscle maintenance, decreased muscle loss, or improved exercise training results.
    Type: Application
    Filed: February 12, 2019
    Publication date: August 8, 2019
    Inventors: David Janow, Ralf Jäger
  • Patent number: 10251415
    Abstract: Some embodiments relate to nutritional supplements comprising rice protein isolate. Some embodiments of the nutritional supplement comprise less than about 90 mg of leucine per gram of rice protein isolate and less than about 50 mg of lysine per gram of rice protein isolate. Some embodiments pertain to methods of using the nutritional supplements described herein to achieve one or more of weight gain, weight maintenance, growth, muscle growth, muscle maintenance, decreased muscle loss, or improved exercise training results.
    Type: Grant
    Filed: July 19, 2017
    Date of Patent: April 9, 2019
    Assignee: Axiom Foods, Inc.
    Inventors: David Janow, Ralf Jäger
  • Publication number: 20180243345
    Abstract: The present invention relates to methods for conferring mTOR mediated physiological benefits by administering a composition having phospholipids, omega-3 fatty acids, and an antioxidant, or a krill extract to a mammal in need thereof.
    Type: Application
    Filed: August 22, 2016
    Publication date: August 30, 2018
    Inventors: David McCray PEELE, Ralf JÄGER, Martin PURPURA
  • Publication number: 20170340572
    Abstract: The disclosed are shelf-stable beta-hydroxyisovaleric acid containing soft gel compositions and methods for making such compositions. In certain aspects, disclosed compositions comprise a plant-based capsule shell and a liquid formulation comprising beta-hydroxyisovaleric acid and at least one excipient, wherein the soft gel capsule is shelf-stable. In certain aspects, the excipient is selected from selected from choline salt, betaine, phosphatidylcholine, alpha-glycerophosphocholine, carnitine, adenosine 5?-triphosphate, or a combination thereof.
    Type: Application
    Filed: May 25, 2017
    Publication date: November 30, 2017
    Inventors: Martin Purpura, Ralf Jager, Jie Gu, Xiong Zheng, lingwei dai, Yaohua Zhang
  • Patent number: 9820504
    Abstract: Some embodiments relate to nutritional supplements comprising rice protein isolate. Some embodiments of the nutritional supplement comprise less than about 90 mg of leucine per gram of rice protein isolate and less than about 50 mg of lysine per gram of rice protein isolate. Some embodiments pertain to methods of using the nutritional supplements described herein to achieve one or more of weight gain, weight maintenance, growth, muscle growth, muscle maintenance, decreased muscle loss, or improved exercise training results.
    Type: Grant
    Filed: March 21, 2014
    Date of Patent: November 21, 2017
    Assignee: Axiom Foods, Inc.
    Inventors: David Janow, Ralf Jäger
  • Publication number: 20170318852
    Abstract: Some embodiments relate to nutritional supplements comprising rice protein isolate. Some embodiments of the nutritional supplement comprise less than about 90 mg of leucine per gram of rice protein isolate and less than about 50 mg of lysine per gram of rice protein isolate. Some embodiments pertain to methods of using the nutritional supplements described herein to achieve one or more of weight gain, weight maintenance, growth, muscle growth, muscle maintenance, decreased muscle loss, or improved exercise training results.
    Type: Application
    Filed: July 19, 2017
    Publication date: November 9, 2017
    Inventors: David Janow, Ralf Jäger
  • Publication number: 20170079311
    Abstract: A method for improving the absorption of amino acids from protein sources include adding one or more carbohydrases to a protein source. Plant protein such as that found in rice may be extracted to provide a rice concentrate useful in regimens requiring elevated amounts of protein consumption. To improve the absorption of the amino acids found in rice inside the human gastrointestinal tract, a carbohydrases such as Alpha-galactidase is added to the protein source prior to ingestion. The composition may also include proteases.
    Type: Application
    Filed: September 17, 2015
    Publication date: March 23, 2017
    Inventors: Ralf Jager, Mark Olson, Joseph P. Mannion, Jaroslav Boublik, Martin Purpura
  • Publication number: 20120141448
    Abstract: Phosphatidic acid is administered orally to increase muscle mass and strength in exercising mammals. Phosphatidic acid is administered orally to aging, bedridden or cachectic patients to improve nitrogen balance. The preferred form of phosphatidic acid for administration is phosphatidic acid-enriched lecithin. Creatine is co-administered orally to increase the muscle-building and strength effect. Other suggested additives include nutritional and herbal supplements, micronutrients and hormones.
    Type: Application
    Filed: November 23, 2011
    Publication date: June 7, 2012
    Inventors: Lorenzo De Ferra, Marvin Heuer, Scott Hagerman, Martin Purpura, Ralf Jäger
  • Patent number: 8129360
    Abstract: The invention concerns the use of phosphatidylserine (PS), lyso-phosphatidylserine or/and a physiologically acceptable salt thereof for the treatment of the attention deficit syndrome (ADHS) in small daily doses over a longer time period and in larger daily doses over a short period as well as in combination with suitable additives selected from the group comprising antioxidants, essential fatty acids, mineral substances, amino acids, mood-lifters or/and phospholipids. In this connection it is preferred to carry out the administration to probands aged 2 to 20 years preferably 3 to 10 years whereby the phosphatidylserine as well as the additives are used in solid and also in liquid formulations. Due to its positive properties phosphatidyl-serine is in particular suitable as a therapeutic agent or food supplement in connection with ADHS. The good tolerance of phosphatidylserine even in high doses and over a longer supplementation period and the excellent compliance should also be stressed.
    Type: Grant
    Filed: October 4, 2002
    Date of Patent: March 6, 2012
    Assignee: Cargill Texturizing Solutions Deutschland GmbH & Co., KG
    Inventors: Ralf Jäger, Dirk Bökenkamp
  • Patent number: 8124594
    Abstract: Methods using phosphatidylserine, lysophosphatidylserine, and/or salts thereof to increase testosterone levels in subjects in need thereof are disclosed herein. The methods can be useful for subjects having age related decline in testosterone, exercise induced decline in testosterone, and/or hypogonadism.
    Type: Grant
    Filed: November 30, 2008
    Date of Patent: February 28, 2012
    Assignee: Chemi Nutra, LLC
    Inventors: Martin Purpura, Ralf Jäger, Scott L. Hagerman
  • Patent number: 7678768
    Abstract: The present invention concerns a physiologically active composition which contains an enzymatically hydrolysed collagen as the active component I and at least one component of the non-vitamin type having anti-oxidative and/or anti-inflammatory properties as the active component II. Collagen of animal origin that is soluble in cold water comes into particular consideration as component I and a fermentation broth or a plant extract comes into particular consideration as component II. This composition which is designed in particular as a food supplement or functional food can be used to prevent inflammatory and/or degenerative symptoms in particular with a chronic course such as for example arthritis and arthroses or to successfully treat these symptoms. The claimed composition can be used above all by professional, leisure and recreational athletes who suffer in particular from strained joint functions.
    Type: Grant
    Filed: July 27, 2005
    Date of Patent: March 16, 2010
    Assignee: Cargill Incorporated
    Inventors: Martin Purpura, Ralf Jäger, Karim Balan, Dietrich Paper
  • Publication number: 20090142425
    Abstract: A physiologically active composition is claimed which comprises effective amounts of at least one compound from the group 4-O-methyldavidigenin, 4?-O-methyldavidigenin, davidigenin, elemicin, isoelemicin, herniarin, demethoxycapillarisin, in particular 6-demethoxycapillarisin and/or 6-demethoxy-3?-methoxy-capillarisin, hispiludin and 9-hydroxy-10E, 12Z, 15Z-octadecatrienoic acid, and also glycosides thereof, in particular glucosides and/or rhamnoglucosides of 4-O-methyldavidigenin and/or 4?-O-methyldavidigenin, salts and derivatives.
    Type: Application
    Filed: July 21, 2005
    Publication date: June 4, 2009
    Inventors: Ralf Jager, Hans-Henning Wenk, Heike Tom Dieck, Hans Ullrich Hoppe, Roland Rabeler
  • Publication number: 20090143339
    Abstract: Methods using phosphatidylserine, lysophosphatidylserine, and/or salts thereof to increase testosterone levels in subjects in need thereof are disclosed herein. The methods can be useful for subjects having age related decline in testosterone, exercise induced decline in testosterone, and/or hypogonadism.
    Type: Application
    Filed: November 30, 2008
    Publication date: June 4, 2009
    Inventors: Martin Purpura, Ralf Jager, Scott L. Hagerman